Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction

Zhejiang Provincial People's Hospital3,000 enrolled

Overview

The aim of this study is to investigate the potential novel risk factors for acute myocardial infarction. Predictors of poor outcomes will be also evaluated.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Coronary Artery Disease Percutaneous Coronary Intervention Acute Myocardial Infarction

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Less than 12 hours after the onset of myocardial infarction symptoms * Myocardial necrosis, as evidenced by increased Creatine Kinase Isoenzyme (CK-MB) or troponin levels Exclusion Criteria: * Age under 18 years-old

Locations (1)

Zhejiang provincial people's hospital

Hangzhou, Zhejiang, China

Outcomes

Primary Outcomes

Major adverse cardiovascular events (MACE)

Composite of angina pectoris, reinfarction, unplanned rehospitalization, stent thrombosis, incidence of cardiac death in the duration of follow-up

Time frame: maximum 5 years

Secondary Outcomes

Length of hospital stay

The length of in-hospital stay is counted as a secondary outcome

Time frame: in the phase of hospital stay, maximum 30 days

New-onset diabetes

New-onset diabetes are defined as newly-diagnosed type 2 diabetes mellitus

Time frame: the duration of follow-up, maximum 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.